The and have announced a $10 million grant from the Indianapolis-based to the in support of the public-private institute's charitable, educational, and scientific activities.
Launched in May to accelerate the discovery, development, and delivery of bioscience and medical technology innovations, the institute will focus its efforts on key health-related challenges, including cardiovascular disease, diabetes, obesity, and proper nutrition. Indeed, research has found that interrelated metabolic disorders are a major economic drag on the U.S. economy and a leading cause of death among Americans, some 35 percent of whom suffer from cardiovascular disease and/or metabolic disorders.
The institute also will use the grant funds to attract and support a cohort of Indiana Fellows, who will collaborate with each other and with industry and academic partners on a series of scientific research projects designed to increase public and private research spending and jobs in the state.
"The institute will foster deep and strategic collaborations among Indiana's life science companies and research institutions that should increase and enhance the state's intellectual capital and strengthen its economy," said Lilly Endowment president and CEO N. Clay Robbins. "The degree of shared commitment of Indiana's life sciences businesses, its research institutions, and state government to growing the research capacity in Indiana is unprecedented. Lilly Endowment is pleased to help support the launch of this exciting new venture that holds great promise for our state."